These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25273564)

  • 1. Virus-like particles as vaccine.
    Chroboczek J; Szurgot I; Szolajska E
    Acta Biochim Pol; 2014; 61(3):531-9. PubMed ID: 25273564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-like particles: potential veterinary vaccine immunogens.
    Liu F; Ge S; Li L; Wu X; Liu Z; Wang Z
    Res Vet Sci; 2012 Oct; 93(2):553-9. PubMed ID: 22100244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric virus-like particles for the delivery of an inserted conserved influenza A-specific CTL epitope.
    Cheong WS; Reiseger J; Turner SJ; Boyd R; Netter HJ
    Antiviral Res; 2009 Feb; 81(2):113-22. PubMed ID: 19007818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.
    Xu J; Guo HC; Wei YQ; Dong H; Han SC; Ao D; Sun DH; Wang HM; Cao SZ; Sun SQ
    Appl Microbiol Biotechnol; 2014 Apr; 98(8):3529-38. PubMed ID: 24413974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pandemic H1N1 influenza virus-like particles are immunogenic and provide protective immunity to pigs.
    Pyo HM; Masic A; Woldeab N; Embury-Hyatt C; Lin L; Shin YK; Song JY; Babiuk S; Zhou Y
    Vaccine; 2012 Feb; 30(7):1297-304. PubMed ID: 22207090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assembly and immunological properties of a bivalent virus-like particle (VLP) for avian influenza and Newcastle disease.
    Shen H; Xue C; Lv L; Wang W; Liu Q; Liu K; Chen X; Zheng J; Li X; Cao Y
    Virus Res; 2013 Dec; 178(2):430-6. PubMed ID: 24050994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric SV40 virus-like particles induce specific cytotoxicity and protective immunity against influenza A virus without the need of adjuvants.
    Kawano M; Morikawa K; Suda T; Ohno N; Matsushita S; Akatsuka T; Handa H; Matsui M
    Virology; 2014 Jan; 448():159-67. PubMed ID: 24314646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza.
    D'Aoust MA; Couture MM; Charland N; Trépanier S; Landry N; Ors F; Vézina LP
    Plant Biotechnol J; 2010 Jun; 8(5):607-19. PubMed ID: 20199612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice.
    Huret C; Desjardins D; Miyalou M; Levacher B; Amadoudji Zin M; Bonduelle O; Combadière B; Dalba C; Klatzmann D; Bellier B
    Vaccine; 2013 Mar; 31(11):1540-7. PubMed ID: 22634300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses of orange-spotted grouper, Epinephelus coioides, against virus-like particles of betanodavirus produced in Escherichia coli.
    Lai YX; Jin BL; Xu Y; Huang LJ; Huang RQ; Zhang Y; Kwang J; He JG; Xie JF
    Vet Immunol Immunopathol; 2014 Jan; 157(1-2):87-96. PubMed ID: 24252246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial superglue enables easy development of efficient virus-like particle based vaccines.
    Thrane S; Janitzek CM; Matondo S; Resende M; Gustavsson T; de Jongh WA; Clemmensen S; Roeffen W; van de Vegte-Bolmer M; van Gemert GJ; Sauerwein R; Schiller JT; Nielsen MA; Theander TG; Salanti A; Sander AF
    J Nanobiotechnology; 2016 Apr; 14():30. PubMed ID: 27117585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achievement of avian influenza virus-like particles that could be used as a subunit vaccine against low-pathogenic avian influenza strains in ducks.
    Prel A; Le Gall-Reculé G; Jestin V
    Avian Pathol; 2008 Oct; 37(5):513-20. PubMed ID: 18798027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of varying antigens and adjuvant systems on the immunogenicity and safety of investigational tetravalent human oncogenic papillomavirus vaccines: results from two randomized trials.
    Van Damme P; Leroux-Roels G; Simon P; Foidart JM; Donders G; Hoppenbrouwers K; Levin M; Tibaldi F; Poncelet S; Moris P; Dessy F; Giannini SL; Descamps D; Dubin G
    Vaccine; 2014 Jun; 32(29):3694-705. PubMed ID: 24674663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen delivery by virus-like particles for immunotherapeutic vaccination.
    Al-Barwani F; Donaldson B; Pelham SJ; Young SL; Ward VK
    Ther Deliv; 2014 Nov; 5(11):1223-40. PubMed ID: 25491672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-adjuvanting influenza candidate vaccine presenting epitopes for cell-mediated immunity on a proteinaceous multivalent nanoplatform.
    Szurgot I; Szolajska E; Laurin D; Lambrecht B; Chaperot L; Schoehn G; Chroboczek J
    Vaccine; 2013 Sep; 31(40):4338-46. PubMed ID: 23880363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Influenza VLP vaccines comprising matrix-2 ectodomain and nucleoprotein epitopes protects mice from lethal challenge.
    Gao X; Wang W; Li Y; Zhang S; Duan Y; Xing L; Zhao Z; Zhang P; Li Z; Li R; Wang X; Yang P
    Antiviral Res; 2013 Apr; 98(1):4-11. PubMed ID: 23416215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Progress on the Versatility of Virus-Like Particles.
    Qian C; Liu X; Xu Q; Wang Z; Chen J; Li T; Zheng Q; Yu H; Gu Y; Li S; Xia N
    Vaccines (Basel); 2020 Mar; 8(1):. PubMed ID: 32244935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice.
    Marsac D; Puaux AL; Rivière Y; Michel ML
    Immunobiology; 2005; 210(5):305-19. PubMed ID: 16164038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of different recombinant rabbit hemorrhagic disease virus-like particles carrying CD8+ T cell epitope from chicken ovalbumin (OVA).
    Chen M; Song Y; Fan Z; Jiang P; Hu B; Xue J; Wei H; Wang F
    Virus Res; 2014 Apr; 183():15-22. PubMed ID: 24457072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strong CD8+ T cell antigenicity and immunogenicity of large foreign proteins incorporated in HIV-1 VLPs able to induce a Nef-dependent activation/maturation of dendritic cells.
    Sistigu A; Bracci L; Valentini M; Proietti E; Bona R; Negri DR; Ciccaglione AR; Tritarelli E; Nisini R; Equestre M; Costantino A; Marcantonio C; Santini SM; Lapenta C; Donati S; Tataseo P; Miceli M; Cara A; Federico M
    Vaccine; 2011 Apr; 29(18):3465-75. PubMed ID: 21382480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.